Vice President, Neurocine Biosciences
Tim is currently a Vice President at Neurocrine Biosciences having served as their Chief Financial Officer from September 2006 to February 2017. Prior to Neurocrine, he served as Vice President of Financial Services at CHI, a nationwide integrated healthcare delivery system. From 1989 to 1999, Mr. Coughlin served as a Senior Manager in the Health Sciences practice of Ernst & Young, and its predecessors. Mr. Coughlin currently serves on the Board of Directors of Fate Therapeutics, a clinical-stage biopharmaceutical company engaged in the discovery and development of pharmacologic modulators of adult stem cells to treat severe, life-threatening diseases, and Retrophin, a rare disease focused biotechnology company. Mr. Coughlin holds a Bachelor’s degree from Temple University and a Master’s in International Business from San Diego State University. He is a CPA in Pennsylvania and California.